Donald Nicholson, PhD

Don has been a member of the board of directors of Disc Medicine, Inc. since April 2019 and previously served as a member of the board of directors of Kymera Therapeutics, Inc. He has also served on the boards of several private companies, including Jnana Therapeutics, NodThera, Muna Therapeutics, and Matchpoint Therapeutics. Don served as chief executive officer of Nimbus Therapeutics from August 2014 to October 2018. Prior to that, he spent 25 years at Merck & Co. in various leadership, strategic, and operational roles. Don earned his Bachelor of Science with honors in biochemistry and his doctorate in biochemistry from the University of Western Ontario, and he trained as a Medical Research Council postdoctoral fellow at the University of Munich in Germany.